Warren Eric
Chief Commercial Officer
Warren Eric has filed 3 SEC Form 4 filings (6 transaction rows) across 1 company, with disclosures dating back to 2026. 3 of those filings fall inside the rolling window. Most recent filing: Aug 25, 2026.
On the most recent filing, Warren Eric is listed as Chief Commercial Officer at Mineralys Therapeutics, Inc. Inside the rolling window, Warren Eric reported no open-market purchases and 3 open-market sales totaling $3.1M in MLYS. The largest disclosed transaction in the window is a sale of 104,124 MLYS shares on Jun 26, 2026, worth $2.7M.
Companies traded
Other insiders at MLYS
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$3.1M
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Warren Eric made?
Warren Eric has filed 3 SEC Form 4 filings (6 transaction rows) across 1 company since 2026.
Which companies does Warren Eric trade?
Warren Eric has filed SEC Form 4 disclosures for 1 company, including MLYS.
When was Warren Eric's most recent SEC Form 4 filing?
Warren Eric's most recent SEC Form 4 filing on Tracefour is dated Aug 25, 2026.
What is Warren Eric's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Warren Eric is listed as Chief Commercial Officer.
What is Warren Eric's total buy and sell value in the current window?
Inside the rolling retention window, Warren Eric bought $0 and sold $3.1M based on SEC Form 4 filings.
What was Warren Eric's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 104,124 MLYS shares on 2026-06-26, worth $2.7M, per SEC Form 4 filings.